Huiqiang Wei
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- Natural product bioactivities and synthesis
- Peroxisome Proliferator-Activated Receptors
Papers in
-
- Ubiquitin and proteasome pathways 3
- Natural product bioactivities and synthesis 3
- DNA Repair Mechanisms 1
-
- NF-κB Signaling Pathways 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Yuqing Duan (4 shared papers)Yong Qin (3 shared papers)Changfen Bi (5 shared papers)Yiliang Li (3 shared papers)Ying Zhao (1 shared paper)Wenfeng Gou (9 shared papers)Yiliang Li (9 shared papers)Qiang Liu (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (3 papers)Cancer Letters (1 paper)Phytomedicine (1 paper)Expert Opinion on Therapeutic Patents (1 paper)ACS Omega (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Huiqiang Wei
16 papers receiving 336 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 60
- Molecular Biology 186
- Oncology 54
- Biochemistry 10
- Organic Chemistry 45
Countries citing papers authored by Huiqiang Wei
This map shows the geographic impact of Huiqiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqiang Wei more than expected).
Fields of papers citing papers by Huiqiang Wei
This network shows the impact of papers produced by Huiqiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqiang Wei. The network helps show where Huiqiang Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiqiang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 124 | |
| 2 | 2019 | 47 | |
| 3 | 2021 | 27 | |
| 4 | 2022 | 21 | |
| 5 | 2020 | 19 | |
| 6 | [Protective action of corynoline, acetylcorynoline and protopine against experimental liver injury in mice]. | 1997 | 18 |
| 7 | 2002 | 15 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2016 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 2 |
About Huiqiang Wei
Huiqiang Wei is a scholar working on Molecular Biology, Cancer Research, Immunology, Organic Chemistry and Pathology and Forensic Medicine, having authored 16 papers that have together received 342 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Natural product bioactivities and synthesis (3 papers), interferon and immune responses (2 papers), NF-κB Signaling Pathways (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), DNA Repair Mechanisms (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Cancer Research (60 citations), Molecular Biology (186 citations), Oncology (54 citations), Biochemistry (10 citations) and Organic Chemistry (45 citations). Huiqiang Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuqing Duan, Yong Qin, Changfen Bi, Yiliang Li, Ying Zhao, Wenfeng Gou, Yiliang Li, Qiang Liu, Deguan Li and Wenbin Hou. Their work appears in journals such as European Journal of Medicinal Chemistry, Cancer Letters, Phytomedicine, Expert Opinion on Therapeutic Patents and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.